New paradigms in the management of prostate cancer

Industry session by SANOFI GENZYME

  • Location:
    Room 14b (ICM, Level 1)
  • Chair:
     B. Tombal, Brussels (BE)
Welcome and introduction
 B. Tombal, Brussels (BE)
Understanding disease heterogeneity to guide treatment choices
 B. Tombal, Brussels (BE)
Redefining the management of advanced prostate cancer to optimise survival
 N.W. Clarke, Manchester (GB)
New hopes for high-risk localised prostate cancer
 H.M. Sandler, Los Angeles (US)
Recommendations for daily practice
 N. Mottet, Saint-√Čtienne (FR)
Discussion and closing remarks
 B. Tombal, Brussels (BE)